0000950170-24-092733.txt : 20240807
0000950170-24-092733.hdr.sgml : 20240807
20240807160504
ACCESSION NUMBER: 0000950170-24-092733
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240805
FILED AS OF DATE: 20240807
DATE AS OF CHANGE: 20240807
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Graul Regina Margaret
CENTRAL INDEX KEY: 0002002981
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38787
FILM NUMBER: 241183537
MAIL ADDRESS:
STREET 1: CYCLERION THERAPEUTICS, INC.
STREET 2: 254 FIRST STREET, 18TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cyclerion Therapeutics, Inc.
CENTRAL INDEX KEY: 0001755237
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 831895370
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-621-7722
MAIL ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
ownership.xml
4
X0508
4
2024-08-05
0001755237
Cyclerion Therapeutics, Inc.
CYCN
0002002981
Graul Regina Margaret
C/O CYCLERION THERAPEUTICS, INC.
245 FIRST STREET, 18TH FLOOR
CAMBRIDGE
MA
02142
true
true
false
false
See Remarks
false
Stock Option (Right to Buy)
3.30
2024-08-05
4
A
false
55849
0
A
2034-08-05
Common Stock
55849
55849
D
The Reporting Person was granted an option to purchase up to 55,849 shares of the Corporation's common stock pursuant to the 2019 Equity Incentive Plan. These 55,849 shares vest ratably in
monthly installments over a 48-month period commencing August 31, 2024 and ending July 31, 2028, provided that the Reporting Person remains employed by Cyclerion Therapeutics, Inc. on such
applicable vesting date, subject to certain exemptions.
President and Chief Executive Officer
/s/ Regina M. Graul
2024-08-07